Treatment of Urosepsis Caused by Yeast
For urosepsis caused by yeast, fluconazole 400 mg (6 mg/kg) daily is the recommended first-line treatment for patients with fluconazole-susceptible Candida species. 1
Initial Assessment and Diagnosis
- Obtain urine and blood cultures before initiating antifungal therapy
- Evaluate for urinary tract obstruction with imaging (ultrasound, CT)
- Assess for disseminated infection with dilated retinal examination within first week of therapy 1
Treatment Algorithm
First-line Treatment:
- Fluconazole-susceptible Candida species:
Alternative Treatments:
For fluconazole-resistant C. glabrata:
- Amphotericin B deoxycholate 0.3-0.6 mg/kg daily for 1-7 days OR
- Oral flucytosine 25 mg/kg 4 times daily 1
For severely ill patients or those with suspected disseminated infection:
- Liposomal Amphotericin B 3-5 mg/kg daily with or without flucytosine 1
- Consider step-down to fluconazole after clinical improvement
Source Control
- Eliminate predisposing factors (indwelling bladder catheters) whenever feasible 1
- For urinary tract obstruction, urgent decompression is required:
- Nephrostomy tube placement or stent insertion
- Removal of stones if present
Special Populations
Neutropenic Patients:
- Treat as for candidemia with an echinocandin (caspofungin 70-mg loading dose, then 50 mg daily; micafungin 100 mg daily; or anidulafungin 200-mg loading dose, then 100 mg daily) 1
- Duration: at least 2 weeks after first negative blood culture and resolution of neutropenia 1
Patients Undergoing Urologic Procedures:
- Oral fluconazole 400 mg (6 mg/kg) daily OR
- Amphotericin B deoxycholate 0.3-0.6 mg/kg daily for several days before and after the procedure 1
Duration of Therapy
- For uncomplicated candiduria with sepsis: minimum 2 weeks of therapy 1
- For pyelonephritis with sepsis: 2-4 weeks of therapy 1
- For disseminated candidiasis: continue until all signs, symptoms, and radiological abnormalities have resolved (typically 4-6 weeks) 1
Monitoring
- Daily assessment of vital signs and clinical status
- Follow-up urine cultures to document clearance
- Monitor renal function if using amphotericin B
- For persistent candiduria, evaluate for structural abnormalities or foreign bodies
Important Caveats
- Asymptomatic candiduria generally does not require treatment unless the patient is at high risk for dissemination (neutropenia, very low birth weight infants) 1
- Fluconazole achieves high urinary concentrations and is preferred over newer azoles and echinocandins, which do not achieve adequate urine concentrations 3
- Removal of urinary catheters alone may clear candiduria in up to 50% of cases 3
- For urinary fungus balls, surgical removal is strongly recommended with antifungal therapy 1
Urosepsis caused by yeast represents approximately 25% of all sepsis cases 4, 5 and requires prompt treatment to prevent complications. Early diagnosis, appropriate antifungal therapy, and control of any complicating factors in the urinary tract are essential for successful management.